Author: Wu, Yingjie; Huang, Xiaoxing; Sun, Jiaxing; Xie, Tian; Lei, Yufei; Muhammad, Jamal; Li, Xinran; Zeng, Xingruo; Zhou, Fuling; Qin, Hong; Shao, Liang; Zhang, Qiuping
Title: Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19 Cord-id: jca8m7du Document date: 2020_7_15
ID: jca8m7du
Snippet: The outbreak of coronavirus disease 2019 (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a threat to global health. The mortality rate of severely ill patients in the early stage is 32.5%. The exacerbation of the condition and death of patients are closely associated with inflammatory cytokine storms, which are caused by excessive activation of the immune and complement systems as well as the coinfection of other pathogens. How
Document: The outbreak of coronavirus disease 2019 (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a threat to global health. The mortality rate of severely ill patients in the early stage is 32.5%. The exacerbation of the condition and death of patients are closely associated with inflammatory cytokine storms, which are caused by excessive activation of the immune and complement systems as well as the coinfection of other pathogens. However, the immunological characteristics and the mechanisms underlying inflammatory storms have not been well elucidated. Here, we analyzed the clinical and immunological characteristics of 71 confirmed COVID-19 patients. Based on the National Health Commission of China (NHCC) guidelines, patients were stratified into mild and severe types. We compared the clinical and laboratory data obtained from electronic medical records between the two types. In regard to the hematological parameters, COVID-19 patients showed decreased erythrocyte count, hemoglobin, hematocrit, lymphocyte count, eosinophil count, and complement C1q, whereas neutrophils, C-reactive protein, and procalcitonin were significantly increased, especially in severe cases. We also found that CD3(+) CD4(+) T lymphocytes, CD3(+) CD8(+) T lymphocytes, CD19(+) B lymphocytes, and CD16(+) CD56(+) NK cells in the peripheral blood of all patients were decreased. In addition, CD3(+) CD8(+) T lymphocytes, CD16(+) CD56(+) NK cells, and complement C1q in severely ill patients decreased more significantly. Additionally, interleukin 6 (IL-6) elevation was particularly prominent in all patients, especially in severe cases. These results suggest that CD3(+) CD8(+) T lymphocytes, CD16(+) CD56(+) NK cells, C1q as well as IL-6 may play critical roles in the inflammatory cytokine storm. The dysregulation of these aforementioned immune parameters, along with bacterial coinfection, were the important causes of exacerbation of the patients’ condition and death. This study improves our understanding of the immune dysregulation of COVID-19 and provides potential immunotherapeutic strategies. IMPORTANCE The dysregulation of CD3(+) CD8(+) T lymphocytes, CD16(+) CD56(+) NK cells, C1q as well as IL-6, along with bacterial coinfection, were important causes of exacerbation of the patients’ condition and death.
Search related documents:
Co phrase search for related documents- absolute count and acute cardiac injury: 1
- absolute count and admission severity assessment: 1
- absolute count and low platelet: 1, 2
- absolute count and lung injury: 1, 2
- aci acute cardiac injury and acute ards respiratory distress syndrome: 1, 2, 3, 4
- aci acute cardiac injury and acute cardiac injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- activation process and acute ards respiratory distress syndrome: 1
- acute ards respiratory distress syndrome and local tissue: 1, 2, 3
- acute ards respiratory distress syndrome and low complement: 1
- acute ards respiratory distress syndrome and low platelet: 1, 2, 3
- acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute cardiac injury and low platelet: 1
- acute cardiac injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- local tissue and lung injury: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date